The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vascular pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vph.2010.12.001PMID 21167314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.

  2010cited by this paper
• Nitric oxide and zinc homeostasis in pulmonary endothelium

  2010cited by this paper
• Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study

  2009cited by this paper
• Arterial stiffness, hypertension, and rational use of nebivolol

  2009cited by this paper
• Neither K + Channels Nor PI3K/Akt Mediates the Vasodilative Effect of Nebivolol on Different Types of Rat Arteries

  2009cited by this paper
• Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.

  2009cited by this paper
• Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.

  2008cited by this paper
• Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization.

  2008cited by this paper
• Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

  2007cited by this paper
• ADMA is independently related to flow‐mediated vasodilation in subjects at low cardiovascular risk

  2007cited by this paper
• Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

  2007cited by this paper
• Reduction of NO- and EDHF-Mediated Vasodilatation in Hypertension: Role of Asymmetric Dimethylarginine

  2007cited by this paper
• Should atenolol still be recommended as first-line therapy for primary hypertension?

  2006cited by this paper
• Role of Asymmetrical Dimethylarginine in Renal Microvascular Endothelial Dysfunction in Chronic Renal Failure with Hypertension

  2005cited by this paper
• Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl l-Arginine Accelerates Endothelial Cell Senescence

  2004cited by this paper
• Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway

  2004cited by this paper
• Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase

  2003cited by this paper
• A method for the extraction of high-quality RNA and protein from single small samples of arteries and veins preserved in RNAlater.

  2002cited by this paper
• Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling

  2002cited by this paper
• Vascular Effects of Newer Cardiovascular Drugs: Focus on Nebivolol and ACE‐Inhibitors

  2001cited by this paper
• Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension: A Randomized, Double-Blind, Crossover Study

  2001cited by this paper
• Does ADMA cause endothelial dysfunction?

  2000cited by this paper
• Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.

  1999cited by this paper
• Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

  1999cited by this paper
• Effects of some guanidino compounds on human cerebral arteries.

  1999cited by this paper
• Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.

  1998cited by this paper
• Modulation of endothelium-derived nitric oxide in canine femoral veins.

  1996cited by this paper
• Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

  1996cited by this paper
• Aging and endothelial function in normotensive subjects and patients with essential hypertension.

  1995cited by this paper
• Quantification of nitrite and nitrate in human urine and plasma as pentafluorobenzyl derivatives by gas chromatography-mass spectrometry using their 15N-labelled analogs.

  1994cited by this paper
• Constitutive calcium-dependent isoform of nitric oxide synthase in the human placental villous vascular tree.

  1993cited by this paper
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure.

  1992cited by this paper

• Oxidative Stress in Maternal and Offspring Kidney Disease and Hypertension: A Life-Course Perspective

  2025cites this paper
• Crosstalk between autophagy and ferroptosis mediate injury in ischemic stroke by generating reactive oxygen species

  2024cites this paper
• Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure.

  2022cites this paper
• Dronedarone induces regression of coronary artery remodeling related to better global antioxidant status

  2019cites this paper
• Effects of tetrahydrobiopterin combined with nebivolol on cardiac diastolic function in SHRs.

  2019cites this paper
• Vascular Cell Glycocalyx-Mediated Vascular Remodeling Induced by Hemodynamic Environmental Alteration

  2018cites this paper
• Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril

  2018cites this paper
• Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway

  2018cites this paper
• Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats

  2017cites this paper
• Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)

  2017cites this paper
• Effect of Certain Pharmacotherapies on Plasma Asymmetric Dimethyl Arginine ( ADMA

  2016cites this paper
• Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats

  2016cites this paper
• Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development

  2016cites this paper
• Effect of nebivolol treatment during pregnancy on the intrauterine fetal growth, mortality and pup postnatal development in the l-NAME-induced hypertensive rats.

  2016cites this paper
• Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?

  2016cites this paper
• Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress.

  2016cites this paper
• Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor

  2016cites this paper
• Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via β3 adrenoceptor-mediated mechanism

  2016cites this paper
• Nebivolol suppresses asymmetric dimethylarginine and attenuates cyclosporine-induced nephrotoxicity and endothelial dysfunction in rats

  2016cites this paper
• Clinical Significance of Endothelial Dysfunction in Essential Hypertension

  2015cites this paper
• Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches.

  2015cites this paper
• Probucol Protects Against Asymmetric Dimethylarginine-Induced Apoptosis in the Cultured Human Brain Microvascular Endothelial Cells

  2015cites this paper
• Short-Term Esmolol Improves Coronary Artery Remodeling in Spontaneously Hypertensive Rats through Increased Nitric Oxide Bioavailability and Superoxide Dismutase Activity

  2014cites this paper
• Beta blockers, nitric oxide, and cardiovascular disease.

  2013cites this paper
• Beneficial effects of nebivolol and hydrochlorothiazide combination in spontaneously hypertensive rats

  2013cites this paper
• Nebivolol treatment improves resistant arterial function and reduces ventricular hypertrophy and angiotensin II in spontaneously hypertension rats

  2013cites this paper
• All beta‐blockers are created equal, but some beta‐blockers are more equal than others

  2013cites this paper
• Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade.

  2012cites this paper
• Vascular Effects of Nebivolol Added to Hydrochlorothiazide in African Americans With Hypertension and Echocardiographic Evidence of Diastolic Dysfunction

  2012cites this paper
• The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients.

  2012cites this paper
• Aktivität und Expression der plazentaren Dimethylarginin-Dimethylaminohydrolase bei gesunden Schwangeren und Frauen mit Präeklampsie

  2012cites this paper
• Mechanisms underlying the endothelium-dependent modulation of vascular tone

  2011cites this paper
• The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

  2011cites this paper
• Avaliação dos efeitos do betabloqueador nebivolol sobre o peritônio em modelo experimental murino de diálise peritoneal

  2011cites this paper